Global Heart Journal

Overview
Identity
View All

publication venue for

Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review. 19:20-20. 2024
Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study. 19:10-10. 2024
Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting.. 19:70. 2024
Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.. 44:931-934. 2023
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update. 16:41. 2021
Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study. 16:68-68. 2021
Clinical Profiles and Outcomes of Heart Failure in Five African Countries: Results from INTER-CHF Study. 16:50. 2021
Self-Reported Prevalence of Chronic Non-Communicable Diseases in Relation to Socioeconomic and Educational Factors in Colombia: A Community-Based Study in 11 Departments. 15:35. 2020
Access to Essential Medicines for Circulatory Diseases: A Call to Action. 14:399-399. 2019
Developing the Core Pillars of Training Global Cardiovascular Health Researchers: Companionship, Light, and Fuel. 14:387-387. 2019
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension Program. 14:391-391. 2019
Factors Affecting Symptom Onset to First-Medical-Contact in Egyptian STEMI Patients. 13:363-364. 2018
Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease. 13:93-93. 2018
Exploring the Barriers to and Facilitators of Using Evidence-Based Drugs in the Secondary Prevention of Cardiovascular Diseases: Findings From a Multistakeholder, Qualitative Analysis. 13:27-27. 2018
Secondary CV Prevention in South America in a Community Setting: The PURE Study. 12:305-305. 2017
World Heart Federation Cholesterol Roadmap. 12:179-179. 2017
Can We Eliminate Rheumatic Fever and Premature Deaths From RHD?. 12:3-3. 2017
OC06_01 Association of Nutrients With Blood Lipids in 19 Countries and 5 Continents: The Pure Study. 11:e6-e6. 2016
OC06_10 Applicability of a Non-Laboratory- and a Laboratory Based Cardiovascular Disease Risk Score Across Seven Regions of the World. 11:e9-e9. 2016
PM297 A WHF-Sponsored Pilot Study of a Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Disease in China: The Takemeds Study. 11:e121-e121. 2016
PT046 Urinary Sodium Excretion Versus Mortality and Cardiovascular Events in Those With and Without Hypertension. 11:e134. 2016
PT073 Lipoprotein(A) and Risk of Myocardial Infarction in Major Ethnic Groups. 11:e138-e138. 2016
PT077 Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans. 11:e139. 2016
World Heart Federation Emerging Leaders Program: An Innovative Capacity Building Program to Facilitate the 25 × 25 Goal. 10:229-229. 2015
Correction. 10:225-225. 2015
Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and Conclusions. 10:135-135. 2015
Reducing Cardiovascular Disease Globally: The World Heart Federation’s Roadmaps. 10:93-93. 2015
Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. 10:99-99. 2015
Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation Roadmap. 10:97-97. 2015
O062 Smoking and perioperative cardiovascular and medical outcomes in patients undergoing non-cardiac surgery. 9:e16-e17. 2014